French consensus: treatment of newly ...
Type de document :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
URL permanente :
Titre :
French consensus: treatment of newly diagnosed restless legs syndrome
Auteur(s) :
Titre de la revue :
Revue neurologique
Nom court de la revue :
Rev. Neurol.
Numéro :
174
Pagination :
515-521
Date de publication :
2018-09-01
ISSN :
0035-3787
Mot(s)-clé(s) en anglais :
Dopaminergic agonists
A2 delta ligands
Opioids
Restless legs syndrome
A2 delta ligands
Opioids
Restless legs syndrome
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Treatment of restless legs syndrome (RLS) must only be considered after a definite positive diagnosis. The RLS phenotype must be characterised precisely, iron deficiency always tested for, and aggravating factors eliminated ...
Lire la suite >Treatment of restless legs syndrome (RLS) must only be considered after a definite positive diagnosis. The RLS phenotype must be characterised precisely, iron deficiency always tested for, and aggravating factors eliminated when possible. Medical treatment is considered for severe or very severe forms and based on dopaminergic agonists, α2δ-1 ligands and/or opioids. First line treatment will be a low-dose monotherapy and the choice of treatment depends on the results of the clinical examination and investigations.Lire moins >
Lire la suite >Treatment of restless legs syndrome (RLS) must only be considered after a definite positive diagnosis. The RLS phenotype must be characterised precisely, iron deficiency always tested for, and aggravating factors eliminated when possible. Medical treatment is considered for severe or very severe forms and based on dopaminergic agonists, α2δ-1 ligands and/or opioids. First line treatment will be a low-dose monotherapy and the choice of treatment depends on the results of the clinical examination and investigations.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Équipe(s) de recherche :
Troubles cognitifs dégénératifs et vasculaires
Date de dépôt :
2019-11-27T13:02:25Z